Escherich G, Zur Stadt U, Borkhardt A, Dilloo D, et al. Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Haematologica 2022;107:1026-1033.
PMID: 34348455